[Follow-up strategies after percutaneous coronary intervention: prognostic stratification and multidisciplinary

Giuseppe Musumeci1, Pompilio Faggiano2, Marco Ferlini3

  • 1S.C. Cardiologia, Ospedale Santa Croce e Carle, Cuneo.

Giornale Italiano Di Cardiologia (2006)
|May 12, 2017
PubMed

Insights

Personalized follow-up after percutaneous coronary intervention (PCI) is crucial. Tailoring strategies based on patient risk profiles can optimize care and manage costs effectively for post-PCI patients.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Public Health

Background:

  • Percutaneous coronary interventions (PCI) are increasingly common globally.
  • Current follow-up strategies post-PCI lack standardization, leading to variable healthcare costs.
  • Optimizing post-PCI care pathways is essential for efficient resource allocation.

Purpose of the Study:

  • To provide practical guidance for tailored follow-up strategies after PCI.
  • To define evidence-based clinical and instrumental evaluations for post-PCI patients.
  • To stratify follow-up based on individual patient risk profiles.

Main Methods:

  • Multidisciplinary expert consensus involving cardiologists, cardiac rehabilitation specialists, and general practitioners.
  • Development of three distinct follow-up strategies.
  • Definition of specific clinical and instrumental assessments for each strategy.

Main Results:

  • Established three tailored follow-up pathways for patients after PCI.
  • Outlined specific types and timing for clinical and instrumental evaluations.
  • Recommendations are risk-stratified to personalize patient management.

Conclusions:

  • A risk-profile-based approach to post-PCI follow-up is recommended.
  • Standardized, yet personalized, follow-up can improve patient outcomes and healthcare efficiency.
  • Multidisciplinary collaboration is key to developing effective post-PCI care guidelines.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
347
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
349
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
523
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
368
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
431
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
303